Programme TEST PAGE
Active Filters
- Wednesday 07th
-
07:00 - 09:00REGISTRATION
-
09:00 - 09:05WELCOME Inspired Minds Sarah Porter, CEO and Founder, InspiredMinds! UN Advisor, LAWS Plenary
-
Sarah Porter, CEO and Founder, InspiredMinds! UN Advisor, LAWS
-
-
09:05 - 09:10WELCOME Novartis Foundation Dr Ann Aerts, Head of Novartis Foundation Plenary
-
Dr Ann Aerts, Head of Novartis Foundation
-
-
09:20 - 09:45HEADLINER: The new era of precision health: from precision discovery to delivery Elena Bonfiglioli, GM, Global Healthcare Strategy Lead, Pharma and Life Sciences, Microsoft Plenary
Healthcare professionals use multiple data sources, each and every day. Clinicians rely on several types, combinations, and sources of data, such as imaging, time series data, and structured and unstructured clinical data. This data allows healthcare professionals to become more multidisciplinary and contribute with different perspectives as they arrive to a diagnosis and decide on patient management.
Methods to merge multiple sources and modalities to implement in patient care and R&D is happening now. By pairing Microsoft’s computational services, cloud, and artificial intelligence (AI) with drug discovery and development capabilities, we can work together to discover new medicines in a more efficient and innovative way. Through these diverse multimodal data sets and computational AI, we can increase the impact of treatment and provide better data-driven insights to deliver the right medicine to the right patient at the right time.
-
Elena Bonfiglioli, GM, Global Healthcare Strategy Lead, Pharma and Life Sciences, Microsoft
-
-
09:45 - 10:10HEADLINER Marco Giannitrapani, VP Global Data & Analytics, Roche Plenary
-
Marco Giannitrapani, VP Global Data & Analytics, Roche
-
-
10:10 - 10:35HEADLINER Novartis Foundation
-
Novartis Foundation
-
-
10:35 - 11:00HEADLINER Plenary
-
11:00 - 11:30REFRESHMENTS & NETWORKING
-
ROOM: EVENT HALL
-
11:30 - 11:55HEADLINER: Building towards an equitable and sustainable Future of Health Lucien Engelen, Edge Fellow, Deloitte Center for the Edge, Deloitte
Patricia Gee, Partner in Life Sciences and Leader Future of Health Initiatives, Deloitte Switzerland PlenaryHealth equity is the fair and just opportunity for every individual to achieve their full potential in all aspects of health and well-being. As we move into a Future of Health driven by highly disruptive technologies, radically interoperable data and increased health consumerism, we must tackle how to harness and accelerate these innovations to address disparities existing across populations and countries.It will take the entire ecosystem to come together in a joint mission to make a sustained and significant impact in health equity across all drivers of health: social, economic, and environmental. Join us to hear more insights and potential ideas for tackling these tough challenges and take part in creating an impact that matters for the Future of Health.
-
Lucien Engelen, Edge Fellow, Deloitte Center for the Edge, Deloitte
-
Patricia Gee, Partner in Life Sciences and Leader Future of Health Initiatives, Deloitte Switzerland
-
-
11:55 - 12:35PANEL DISCUSSION: CyberSecurity: essential strategies for incident response and recovery Dr Sabina Magalini, PANACEA coordinator; Senior Surgeon of Emergency Trauma, Gemelli University Hospital
Richard Plumb, Cyber Threat Intelligence Lead, NHS Digital Plenary-
Dr Sabina Magalini, PANACEA coordinator; Senior Surgeon of Emergency Trauma, Gemelli University Hospital
-
Richard Plumb, Cyber Threat Intelligence Lead, NHS Digital
-
-
12:35 - 13:00AI IN GLOBAL HEALTH: HEADLINER Plenary
-
-
ROOM: MCH LOUNGE
-
11:30 - 12:30WORKSHOP 1 Track 1
-
12:30 - 13:15WORKSHOP 2: PANEL DISCUSSION: Using data to improve decision-making in population health Mathieu Morand – Senior Manager, Digital & Health Financing, Cancer City Challenges
Valerie Lasry, Director, Europe, Middle East, Africa and Latin America, NuraLogix Corporation
Moderator: Bruno Villetelle, Head of Data and Digital, Novartis Global Drug Development Track 1-
Mathieu Morand – Senior Manager, Digital & Health Financing, Cancer City Challenges
-
Valerie Lasry, Director, Europe, Middle East, Africa and Latin America, NuraLogix Corporation
-
Moderator: Bruno Villetelle, Head of Data and Digital, Novartis Global Drug Development
-
-
-
13:00 - 14:00LUNCH & NETWORKING
-
PLENARY
-
14:00 - 14:20HEADLINER Plenary
-
14:20 - 14:40HEADLINER Dr John Halamka, President, Mayo Clinic Platform Plenary
-
Dr John Halamka, President, Mayo Clinic Platform
-
-
14:40 - 15:00DEEP DIVE TECH TALK: Accelerating Intelligent Health: The Role of Privacy-Enhancing Technology Dr. Suraj Kapa, SVP Healthcare, TripleBlind Plenary
-
Dr. Suraj Kapa, SVP Healthcare, TripleBlind
-
-
15:00 - 15:40PANEL DISCUSSION: Addressing interoperability and barriers to adoption to create a future driven by precision health Dr. Jim Ritchie, Consultant Renal Physician; Chief Clinical Information Officer; Deputy Director for Research and Innovation, Northern Care Alliance NHS Foundation Trust
Dr. Felice Burn, Clinical Artificial Intelligence Lead, Kantonsspital Aarau AG
Dr Ann Aerts, Head of Novartis Foundation
Moderator: Antonio Russo, Partner, Innovation Leader and Partner, Head of Analytics & Cognitive, Deloitte Switzerland Plenary- Removing silos to offer more integrated care
- Best Practice in Integrated Care – What does success look like?
- Challenges and opportunities
- Focus on patient-centric care
- Addressing inherent privacy issues
-
Dr. Jim Ritchie, Consultant Renal Physician; Chief Clinical Information Officer; Deputy Director for Research and Innovation, Northern Care Alliance NHS Foundation Trust
-
Dr. Felice Burn, Clinical Artificial Intelligence Lead, Kantonsspital Aarau AG
-
Dr Ann Aerts, Head of Novartis Foundation
-
Moderator: Antonio Russo, Partner, Innovation Leader and Partner, Head of Analytics & Cognitive, Deloitte Switzerland
-
15:40 - 16:00HEADLINER Harnessing the power of platform technology for medical imaging AI Dr Imran Siddiqui, UK/I Radiology Medical Advisor, Bayer Plc Plenary
Healthcare services around the world face growing resource and regulatory challenges of deploying multiple AI technologies. Platform technology is well known in many industries and has the potential to revolutionise deployment within healthcare. Understanding the established workflow is a critical step towards effective integration, allowing organisations, healthcare professionals and subsequently their patients to leverage the benefits of AI collectively through one single platform.
-
Dr Imran Siddiqui, UK/I Radiology Medical Advisor, Bayer Plc
-
-
-
ROOM: MCH LOUNGE
-
14:00 - 16:00African Startup Pitches Introduction: Lucy Setian, Director of Digital Transformation, Novartis Foundation
Startups: Hannan Hashmi, Co-CEO, Kapsule
Femi Amoo, CTO & Head of Engineering, Kapsule
Ginyu Innocentia KwalarToh, CEO & Founder, Klarah
Niels Van Espen, Start-up Advisor, Klarah
Babajide Oke, CEO & Founder, Render Health John Shoboiki, CMO, Render Health
Peace Iraguha, COO & Co-founder, Lifesten
Theophila Huriro Uwacu, Director, E-Heza Data Solutions
Aloys Rukundo, Founder & CEO, Hellomed
Louis Henry Kamulegeya, Projects Manager, Rocket Health
Natasha Umuhoza, Projects Officer, Rocket Health
Nelson Igbiriki, CEO & Co-Founder, Medtech Africa Track 1-
Introduction: Lucy Setian, Director of Digital Transformation, Novartis Foundation
-
Startups: Hannan Hashmi, Co-CEO, Kapsule
-
Femi Amoo, CTO & Head of Engineering, Kapsule
-
Ginyu Innocentia KwalarToh, CEO & Founder, Klarah
-
Niels Van Espen, Start-up Advisor, Klarah
-
Babajide Oke, CEO & Founder, Render Health John Shoboiki, CMO, Render Health
-
Peace Iraguha, COO & Co-founder, Lifesten
-
Theophila Huriro Uwacu, Director, E-Heza Data Solutions
-
Aloys Rukundo, Founder & CEO, Hellomed
-
Louis Henry Kamulegeya, Projects Manager, Rocket Health
-
Natasha Umuhoza, Projects Officer, Rocket Health
-
Nelson Igbiriki, CEO & Co-Founder, Medtech Africa
-
-
-
16:00 - 16:20REFRESHMENTS & NETWORKING
-
PLENARY
-
16:20 - 16:40HEADLINER Healthcare’s Yin and Yang: Analytics and Clinical Empathy Dr Daniel Knecht, VP, Chief Clinical Innovation Officer, CVS Caremark Plenary
Engaging patients with their care supports better health and lower costs. The premise is simple: engagement can help patients adhere to therapy and prevent gaps in care that contribute to subpar outcomes and unnecessary spending. However, the U.S. healthcare system has an engagement problem. Even prior to the pandemic, fewer than 50% of patients were highly engaged in their care. This is particularly problematic for people managing complex and chronic conditions.
Insights and predictions derived from claims data combined with digital tools and patient reported outcome metrics can help us take a more holistic look at a person’s health and even address co-morbidities. However, that alone is not enough. Clinical empathy – the sense of human connection and emotion between provider and patient – remains critical as we seek to improve health care.
Advanced analytics – making data work smarter – and clinically empathetic human interactions are intimately related and together help drive increasingly personalized and timely patient engagement that will elevate the standard of care in the U.S.
-
Dr Daniel Knecht, VP, Chief Clinical Innovation Officer, CVS Caremark
-
-
16:40 - 17:20PANEL DISCUSSION: Does a tech-driven healthcare sector, fuelled by personalised biometric data, have the potential to ease pressure on centralised healthcare systems and the expenses that go with that ? Caoimhe Vallely-Gilroy, Former Global Head of Digital Health & Therapeutics, Healthcare Business of Merck
Victor Savevski, Chief innovation Officer and AI Center Director, Humanitas Research Hospital
Lucy Setian, Director of Digital Transformation, Novartis Foundation
Moderator: Lucas Scherdel, Director at DayOne - Healthcare Innovation Plenary- Examining the benefits of digital therapeutics in improving health outcomes in patients.
- Are partnerships between digital therapeutics companies and big Pharma critical for this success?
- Merging the use of big data, advanced analytics, and hardware engineering with Big Pharma biological expertise and institutional know-how
- How should regulators and governments adjust to support this blossoming ecosystem?
- Will digital health solutions exacerbate existing disparities?
-
Caoimhe Vallely-Gilroy, Former Global Head of Digital Health & Therapeutics, Healthcare Business of Merck
-
Victor Savevski, Chief innovation Officer and AI Center Director, Humanitas Research Hospital
-
Lucy Setian, Director of Digital Transformation, Novartis Foundation
-
Moderator: Lucas Scherdel, Director at DayOne - Healthcare Innovation
-
17:20 - 17:40HEADLINER Plenary
-
-
ROOM: MCH LOUNGE
-
16:20 - 17:40African Startup Pitches Startups: Chris Mulhall, CEO & Founder, Remote Doctors for All Peter Hurst BDM, Remote Doctors for All
Moses Mukundi, CEO, Eden Care
Clivate Maiba, CEO, Denga Logistics Ltd
Affiong Osuchukwu, Co-Founder, Digi-Dibia Health-Tech Ltd
Audace Nakeshimana, Founder, Insightiv Track 1-
Startups: Chris Mulhall, CEO & Founder, Remote Doctors for All Peter Hurst BDM, Remote Doctors for All
-
Moses Mukundi, CEO, Eden Care
-
Clivate Maiba, CEO, Denga Logistics Ltd
-
Affiong Osuchukwu, Co-Founder, Digi-Dibia Health-Tech Ltd
-
Audace Nakeshimana, Founder, Insightiv
-
-
-
17:40 - 17:40CLOSE OF SUMMIT DAY ONE
-
17:40 - 17:40NETWORKING DRINKS
- Thursday 08th
-
08:00 - 09:00REGISTRATION
-
09:00 - 09:05WELCOME Inspired Minds Sarah Porter, CEO and Founder, InspiredMinds! UN Advisor, LAWS Plenary
-
Sarah Porter, CEO and Founder, InspiredMinds! UN Advisor, LAWS
-
-
09:20 - 09:45HEADLINER Computational Collective Surgical Consciousness Dr Ozanan Meireles, Surgeon at Massachusetts General Hospital; Assistant Professor of Surgery at Harvard Medical School; Co-Founder and Director of the Surgical Artificial Intelligence and Innovation Laboratory (SAIIL) at the Massachusetts General Hospital. Plenary
Artificial Intelligence will be an integral part of surgery in the near future. The use of computer vision and advanced machine learning techniques can change how operations will be performed by allowing surgeons to contribute to and benefit from the knowledge of their colleagues worldwide, conceptually creating a computational collective surgical consciousness. This would enhance surgeon’s skill acquisition and cognitive performance with the potential of mitigating intraoperative adverse events, improving patient care, and reducing health care costs.
-
Dr Ozanan Meireles, Surgeon at Massachusetts General Hospital; Assistant Professor of Surgery at Harvard Medical School; Co-Founder and Director of the Surgical Artificial Intelligence and Innovation Laboratory (SAIIL) at the Massachusetts General Hospital.
-
-
09:45 - 10:25PANEL DISCUSSION The Rise of Femtech: How can digital technology and AI help deliver the women’s health strategy? Mame Daba Diouf, Business Unit & Project Manager, IT4Life
Valentina Sartori, Partner, Leader of QuantumBlack in Switzerland, QuantumBlack, AI by McKinsey Plenary- Addressing the gender health gap
- Driving ‘femtech’ innovation and unlocking opportunities in women’s healthcare
- Empowering women to take control of their wellness
-
Mame Daba Diouf, Business Unit & Project Manager, IT4Life
-
Valentina Sartori, Partner, Leader of QuantumBlack in Switzerland, QuantumBlack, AI by McKinsey
-
10:25 - 10:45REFRESHMENTS & NETWORKING
-
TRACK 1: PRACTICAL, REAL-WORLD AI USE CASES IN HEALTHCARE. Examining the potential to transform care delivery and life science research, challenges faced and lessons learnt. ROOM: EVENT HALL Babita Sharma, Broadcaster and Author
-
10:45 - 11:05AI IN ACTION: USE CASE. Augmenting Imaging Data with AI to bring Precision Therapies to Healthcare & Life Sciences Jacques Gilbert, Senior Director Strategy – Healthcare, Nuance Communications
Artificial Intelligence in imaging is detecting diseases like cancer and aneurysms in early stage to target treatment options and deliver better outcomes. Now, an AI-powered cloud platform is extending patient specific data and diagnostic insights beyond the radiologists and into the connected healthcare ecosystem of providers, health insurers, life sciences and medical technology companies. This keynote will spotlight how AI generated imaging data is shared, scaled and used in care workflows to identify patients for clinical trials and deliver insights into precision therapeutics that cross the care continuum.
-
Jacques Gilbert, Senior Director Strategy – Healthcare, Nuance Communications
-
-
11:05 - 11:25Use Case 2 Notes from the front line - building AI models for messy, real-world data formats
Improving patient outcomes and drug development with AI relies on high-quality models that clinicians can trust. Shoehorning real-world data into formats consumed by traditional AI models can create AI that lacks ‘common-sense’, and limits performance.
Graph abstractions are a flexible format well-suited to real-world data, and the accompanying branch of deep learning: Graph Neural Networks (GNNs), enable powerful models to be built on top of them. Join Luke for practical and effective use-cases of GNNs, and how to run them efficiently in production.
-
11:25 - 12:05PANEL DISCUSSION Harnessing Virtual Health & Care solutions to transform population health and equity Dr Ann Aerts, Head of Novartis Foundation
Prof. S. Yunkap Kwankam, PhD., Executive Director, International Society for Telemedicine and eHealth (ISfTeH)
Caroline Perrin, PhD, Executive Director, Geneva Digital Health Hub (gdhub)
Marco Obiso, Chief AI of the Digital Networks & Society Department, Telecommunication Development Bureau, International Telecommunication Union (ITU)
Jürg Hutter, Senior Product Manager Digital Health, Swiss Post Communication Services Ltd
Natasha Sunderji, Global Health Lead, Accenture Development Partnerships, Accenture-
Dr Ann Aerts, Head of Novartis Foundation
-
Prof. S. Yunkap Kwankam, PhD., Executive Director, International Society for Telemedicine and eHealth (ISfTeH)
-
Caroline Perrin, PhD, Executive Director, Geneva Digital Health Hub (gdhub)
-
Marco Obiso, Chief AI of the Digital Networks & Society Department, Telecommunication Development Bureau, International Telecommunication Union (ITU)
-
Jürg Hutter, Senior Product Manager Digital Health, Swiss Post Communication Services Ltd
-
Natasha Sunderji, Global Health Lead, Accenture Development Partnerships, Accenture
-
-
12:05 - 12:25Keynote Use Case 3
annalise.ai
-
12:25 - 12:45AI IN GLOBAL HEALTH: Use Case 4
-
-
TRACK 2: DEEP DIVE AI TECH TALKS IN HEALTHCARE Fundamental breakthroughs using AI which will change lives and reshape healthcare ROOM: BOSTON
-
10:45 - 11:05Tech Talk 1 Automated Classification and Entity Extraction from Clinical Trial Master Files Veysel Kocaman, Head of Data Science (Healthcare), John Snow Labs
This talk will cover lessons learned from an end-to-end migration process of the clinical trial master files in Novartis. We present a solution based on the natural language processing (NLP) system that delivers a future-proof architecture that comprises OCR based text extraction, language detection, layout & content-based document classifiers, more than 40+ different DL based named entity recognition models, handwritten text extraction, and artifact-based post-processing rules to automate the migration between different document management systems in an air-gapped network. The delivered solution provides 80% reduction of manual labor and migration timeline and is proven in major real-world projects with state of the art accuracy.
-
Veysel Kocaman, Head of Data Science (Healthcare), John Snow Labs
-
-
11:05 - 11:25Tech Talk 2 Applications of Natural Language Processing in Healthcare: Opportunities and challenges Elif Ozkirimli, Head of Products, Computational Science and Analytics, Integrated Informatics, Roche AG
-
Elif Ozkirimli, Head of Products, Computational Science and Analytics, Integrated Informatics, Roche AG
-
-
11:25 - 11:45Tech Talk 3 A comprehensive AI in healthcare evaluation framework and its application Dr Sandeep Reddy, Director, Healthcare Management Program, Deakin University
While there has been incredible excitement about the prospects of AI in healthcare and increasing funding to support its application, there has been a minimal translation of the potential, as evidenced by the few applications used in clinical practice currently. This is mainly because many AI applications are not developed for real-world integration and use by clinical practitioners. We developed a comprehensive AI in healthcare evaluation framework to address this translational gap. This presentation outlines the evaluation framework, its components, and findings from its application. We anticipate that the evaluation framework will be helpful for AI application development in healthcare.
-
Dr Sandeep Reddy, Director, Healthcare Management Program, Deakin University
-
-
11:45 - 12:05Tech Talk 4
-
12:05 - 12:25Tech Talk 5: Combining the AI and neural implants to restore the sensorimotor function in patients Prof Dr Stanisa Raspopovic, Dep. of Health Sciences and Technology, ETH Zürich
-
Prof Dr Stanisa Raspopovic, Dep. of Health Sciences and Technology, ETH Zürich
-
-
12:25 - 12:45Tech Talk 6
-
-
TRACK 3: INNOVATION STAGE: AI HEALTH TRANSFORMERS. Hear from the leaders of the most disruptive AI health tech companies of tomorrow. ROOM: SHANGHAI Frank Dannacher, Director, AI & Data Practice Lead for Life Science and Healthcare, Deloitte Switzerland
-
11:05 - 11:25Innovation Insight 2: The Rise of Simple Models - Interpretable AI for Biomarker and Target Discovery Samuel Demharter, PhD, Head of Bioinformatics, Target & Biomarker Discovery, Abzu
-
Samuel Demharter, PhD, Head of Bioinformatics, Target & Biomarker Discovery, Abzu
-
-
11:25 - 11:45Innovation Insight 3 Blaise Thomson, CEO & Founder, Bitfount
-
Blaise Thomson, CEO & Founder, Bitfount
-
-
11:45 - 12:05Innovation Insight 4
-
12:05 - 12:25Innovation Insight 5
-
12:25 - 12:45Innovation insight 6
-
-
TRACK 4: AI UNDER THE HOOD: WORKSHOPS. ROOM: DELHI
-
10:45 - 11:45Workshop 3: Unleashing the Power of Data through Scaled Deployment of Data Products Nishant Sinha, Director, AI & Automation, Deloitte Switzerland
Peter Hackel, Head of Data Products, Takeda PharmaTakeda’s global manufacturing, supply, and quality organizations (GMS GQ) are utilizing the power of data and AI to transform a landscape of siloed data sets, into consolidated contextualized organizational data – A single source of access to contextualized data enables building and scaling of data products, empowering the organization to make proactive data driven decisions, increase innovations and actualize time savings. Ultimately translating to enhanced quality and delivery of treatment to patients.
-
Nishant Sinha, Director, AI & Automation, Deloitte Switzerland
-
Peter Hackel, Head of Data Products, Takeda Pharma
-
-
11:50 - 12:50Workshop 5: Data-Driven Decision-Making in Healthcare Workshops Hosts: Dr Umang Patel, NHS doctor; CCIO, Microsoft
Dr Arnaud Wilmet, MD, Chief Medical Information Officer, NuanceJoin us for an interactive conversation centered on unlocking the value of healthcare data. If doctors and researchers are empowered to effectively manage and analyze data, they can prepare for future pandemics, discover new therapeutics faster, and observe symptoms earlier. We will discuss how to implement purpose-built cloud solutions to harness the value of healthcare data and how applying AI can help accelerate breakthroughs. You will get an opportunity to hear from health and life sciences leaders on use cases of implementing cloud and AI to support clinical decision making when patients need it most.
-
Workshops Hosts: Dr Umang Patel, NHS doctor; CCIO, Microsoft
-
Dr Arnaud Wilmet, MD, Chief Medical Information Officer, Nuance
-
-
-
TRACK 5: AI UNDER THE HOOD: WORKSHOPS. ROOM: MCH LOUNGE
-
10:45 - 11:45Workshop 4
-
11:50 - 12:50Workshop 6: The Power of Opportunistic Detection using AI Panellists: Dr. Jacob J Visser, Radiologist & CMIO, Assistant professor Value-Based Imaging, Erasmus Medical Center
-
Panellists: Dr. Jacob J Visser, Radiologist & CMIO, Assistant professor Value-Based Imaging, Erasmus Medical Center
-
-
-
12:45 - 13:40LUNCH & NETWORKING
-
TRACK 1: PRACTICAL, REAL-WORLD AI USE CASES IN HEALTHCARE. Examining the potential to transform care delivery and life science research, challenges faced and lessons learnt. ROOM: EVENT HALL Chair: Babita Sharma, Broadcaster and Author
-
13:40 - 12:00HEADLINER Use Case 5
-
14:00 - 14:20Use Case 6: End-to-End AI-driven Robotic Drug Discovery and Case Study of the First AI-Discovered and AI-Designed Therapeutic in Human Clinical Trials Alex Zhavoronkov, Founder and CEO, Insilico Medicine
Since 2014, AI systems have advanced and outperformed humans in many areas. However, in drug discovery and development the number of drugs where the target was discovered using AI or a small molecule was designed using AI is surprisingly small. Here we will present the case study of the first AI-discovered target and AI-designed molecule targeting fundamental pathways implicated in ageing and chronic diseases reaching human clinical trials. We will also present how this process of target discovery and validation can be accelerated and improved using AI-driven robotics systems.
-
Alex Zhavoronkov, Founder and CEO, Insilico Medicine
-
-
14:20 - 14:40Use Case 7: Enhancing Clinical Care by Developing and Applying AI Within a Health System Dr Sumeet S. Chugh, Director, Division of Artificial Intelligence in Medicine; Director, Center for Cardiac Arrest Prevention, Smidt Heart Institute; Cedars-Sinai Health System
There are significant advantages to developing and testing health care AI within learning health systems. The Division of Artificial Intelligence in Medicine in the Cedars-Sinai Health System, Los Angeles, enables cross-disciplinary connections between clinicians, scientists, and trainees within the health system. We employ a patient and disease-based approach for the development of novel clinical tools that address major knowledge gaps in health care.
-
Dr Sumeet S. Chugh, Director, Division of Artificial Intelligence in Medicine; Director, Center for Cardiac Arrest Prevention, Smidt Heart Institute; Cedars-Sinai Health System
-
-
14:40 - 15:00AI IN GLOBAL HEALTH; Use Case 8: AI-Driven Transformation
-
15:00 - 15:20Use Case 9
-
15:20 - 15:40AI IN ACTION: HEADLINER USE CASE 10
-
-
TRACK 2: DEEP DIVE AI TECH TALKS IN HEALTHCARE Fundamental breakthroughs using AI which will change lives and reshape healthcare ROOM: BOSTON
-
13:40 - 14:00Tech Talk 7
-
14:00 - 14:20Tech Talk 8
-
14:20 - 14:40Tech Talk 9
-
14:40 - 15:00Tech Talk 10
-
15:00 - 15:20Tech Talk 11: The Digital Pill: Using a second-generation AI for improving effectiveness of chronic drugs Yaron Ilan, Director of the Department of Medicine, Hebrew University-Hadassah Medical Center
Dr Noa Hurvitz, Resident, Department of Medicine, Hebrew University-Hadassah Medical CenterThe Digital Pill combines a personalized second-generation artificial intelligence system with a branded or generic drug and improves medication response. It provides advantages for all players in the healthcare system, including patients, clinicians, healthcare authorities, and insurance companies. The system provides drug manufacturers with a market differentiator for branded and generic drugs
-
Yaron Ilan, Director of the Department of Medicine, Hebrew University-Hadassah Medical Center
-
Dr Noa Hurvitz, Resident, Department of Medicine, Hebrew University-Hadassah Medical Center
-
-
15:20 - 15:40Tech Talk 12: Automated recognition of function, activity and participation of COVID-19 patients with natural language processing Edwin Geleijn, Physiotherapist / healthcare innovator, Amsterdam UMC
-
Edwin Geleijn, Physiotherapist / healthcare innovator, Amsterdam UMC
-
-
-
TRACK 3: INNOVATION STAGE: AI HEALTH TRANSFORMERS. Hear from the leaders of the most disruptive AI health tech companies of tomorrow. ROOM: SHANGHAI Frank Dannacher, Director, AI & Data Practice Lead for Life Science and Healthcare, Deloitte Switzerland
-
13:40 - 15:00Innovation Insight 7
-
14:00 - 14:20Innovation Insight 8
-
14:20 - 15:40Startups Showcase Judges:
Cécile Tardy-Srinivasan, DayOne Health 4.0 Accelerator Manager, DayOne
Niels Van Espen, Health Innovation & Design Director, MadeFive AI startups short-listed for our showcase get 10 minutes to pitch their business idea to five judges.
After each pitch, judges get 5 minutes to ask questions about the venture.
-
Judges:
-
Cécile Tardy-Srinivasan, DayOne Health 4.0 Accelerator Manager, DayOne
-
Niels Van Espen, Health Innovation & Design Director, Made
-
-
-
TRACK 4: AI UNDER THE HOOD: WORKSHOPS. ROOM: DELHI
-
13:40 - 14:40Workshop 7
-
14:40 - 15:40Workshop 9: Can we holistically quantify financial returns for investment made in hospital AI? Workshop Hosts: Prateek Bharadwaj, Global Market Access Manager, Radiology, Bayer AG
Michael Blankenburg, Market Access Manager, Radiology, Bayer AG
Juan Gutiérrez Alliende, Medical Lead EMEA Digital Solution Business, Radiology, Bayer AGAI-supported digital applications are being developed by Bayer which aim to support the radiologists manage their daily workload by the virtue of augmented efficiency, enriched information, and potentially improved patient outcomes. This interactive workshop explores how we can translate these value attributes into a tangible and measurable benefits (KPIs) framework.
-
Workshop Hosts: Prateek Bharadwaj, Global Market Access Manager, Radiology, Bayer AG
-
Michael Blankenburg, Market Access Manager, Radiology, Bayer AG
-
Juan Gutiérrez Alliende, Medical Lead EMEA Digital Solution Business, Radiology, Bayer AG
-
-
-
TRACK 5: AI UNDER THE HOOD: WORKSHOPS. ROOM: MCH LOUNGE
-
13:40 - 14:40Workshop 8
-
14:40 - 15:40Workshop 10
-
-
15:40 - 16:00REFRESHMENTS & NETWORKING
-
16:00 - 16:25IN CONVERSATION Reimagining the Future of Health: Leveraging technological innovation to mitigate disparities in healthcare and ensure democratic access to medicine for all Dr Geeta Nayyar, SVP, Chief Medical Officer, Salesforce
Interviewer: Stefan Germann, CEO, Fondation Botnar-
Dr Geeta Nayyar, SVP, Chief Medical Officer, Salesforce
-
Interviewer: Stefan Germann, CEO, Fondation Botnar
-
-
16:25 - 16:55PANEL DISCUSSION: Avoiding the hype: What will the future of healthcare REALLY look like? Kelly McCain, Head of Health and Healthcare Initiatives, World Economic Forum
Meni Styliadou, VP Distinguished Fellow, Data Science Institute at Takeda R&D; Founder & Co-Lead of H2O Enterprise
Moderator: Vicky Levy, Deloitte Global Life Sciences Sector Leader, Deloitte-
Kelly McCain, Head of Health and Healthcare Initiatives, World Economic Forum
-
Meni Styliadou, VP Distinguished Fellow, Data Science Institute at Takeda R&D; Founder & Co-Lead of H2O Enterprise
-
Moderator: Vicky Levy, Deloitte Global Life Sciences Sector Leader, Deloitte
-
-
16:55 - 16:55CLOSE OF INTELLIGENT HEALTH